Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8947 |
High Similarity |
NPD6559 |
Discontinued |
0.8909 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD3818 |
Discontinued |
0.8814 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8663 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD6959 |
Discontinued |
0.8613 |
High Similarity |
NPD7074 |
Phase 3 |
0.8555 |
High Similarity |
NPD7054 |
Approved |
0.8545 |
High Similarity |
NPD4380 |
Phase 2 |
0.8523 |
High Similarity |
NPD8313 |
Approved |
0.8523 |
High Similarity |
NPD8312 |
Approved |
0.8506 |
High Similarity |
NPD7472 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8478 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8409 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8393 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8393 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8372 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8362 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8362 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8353 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8342 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8316 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8294 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8256 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8245 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8245 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8245 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8242 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8242 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8242 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8235 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8207 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8207 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8201 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.8201 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8168 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.814 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD37 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8083 |
Intermediate Similarity |
NPD7874 |
Approved |
0.8083 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8081 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8081 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8081 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8075 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8041 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8041 |
Intermediate Similarity |
NPD7801 |
Approved |
0.8041 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7966 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7955 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7944 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7917 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7917 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7861 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7861 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7802 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7753 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7753 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7751 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7751 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7725 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7719 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7709 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7685 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7679 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7665 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7657 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7602 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7585 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7585 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7545 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7545 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD920 |
Approved |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7399 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7389 |
Intermediate Similarity |
NPD919 |
Approved |
0.7385 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3748 |
Approved |
0.738 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.735 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.73 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7263 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD6273 |
Approved |
0.724 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7236 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7229 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7164 |
Intermediate Similarity |
NPD7999 |
Approved |
0.716 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7143 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7104 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7052 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD8491 |
Approved |
0.7028 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7024
|
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |